出院后 COVID-19 患者“复发”的治疗和随访：中国贵州的数据。
The treatment and follow-up of 'recurrence' with discharged COVID-19 patients: data from Guizhou, China.
机构信息
Department of Nephrology, Institute of Nephritic and Urinary Disease, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Guizhou Staff Hospital, Guiyang, China.
出版信息
Environ Microbiol. 2020 Aug;22(8):3588-3592. doi: 10.1111/1462-2920.15156. Epub 2020 Jul 29.
Abstract
We reported 20 cases of discharged COVID-19 patients whose RT-PCR test results showed 're-positive'. After finding 're-positive', these patients were admitted to hospital for the second time and were followed up until the end of May 2020. We recorded detailed treatment and follow-up process, and collected relevant data. The possible causes and potential clinical significance of this phenomenon are discussed.
摘要
我们报告了 20 例出院的 COVID-19 患者，其 RT-PCR 检测结果显示“复阳”。发现“复阳”后，这些患者再次入院，随访至 2020 年 5 月底。我们记录了详细的治疗和随访过程，并收集了相关数据。讨论了这种现象的可能原因和潜在临床意义。
相似文献
1
The treatment and follow-up of 'recurrence' with discharged COVID-19 patients: data from Guizhou, China.出院后 COVID-19 患者“复发”的治疗和随访：中国贵州的数据。
Environ Microbiol. 2020 Aug;22(8):3588-3592. doi: 10.1111/1462-2920.15156. Epub 2020 Jul 29.
2
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR.经 RT-PCR 检测 SARS-CoV-2 再次呈阳性的 COVID-19 患者的临床、免疫学和病毒学特征。
EBioMedicine. 2020 Sep;59:102960. doi: 10.1016/j.ebiom.2020.102960. Epub 2020 Aug 24.
3
SARS-CoV-2 detection in patients with influenza-like illness.SARS-CoV-2 检测在流感样疾病患者中的应用。
Nat Microbiol. 2020 May;5(5):675-678. doi: 10.1038/s41564-020-0713-1. Epub 2020 Apr 7.
4
Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2).6种获批的新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）逆转录聚合酶链反应（RT-PCR）试剂盒的检测限
Clin Chem. 2020 Jul 1;66(7):977-979. doi: 10.1093/clinchem/hvaa099.
5
Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.SARS-CoV-2 PCR 循环阈值分布为有症状患者的整体和目标特异性灵敏度提供了实用见解。
Am J Clin Pathol. 2020 Sep 8;154(4):479-485. doi: 10.1093/ajcp/aqaa133.
6
Re-emergence of SARS-CoV2 in a discharged COVID-19 case.新冠康复者中出现新冠病毒再次感染情况。
J Microbiol Immunol Infect. 2020 Jun;53(3):501-502. doi: 10.1016/j.jmii.2020.03.031. Epub 2020 Apr 2.
7
Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing, China.重新评估新冠肺炎康复患者中复阳核酸检测阳性病例：来自中国重庆某定点转诊医院的报告。
J Infect Public Health. 2020 Jul;13(7):932-934. doi: 10.1016/j.jiph.2020.06.008. Epub 2020 Jun 7.
8
Quality of Ribonucleic Acid Extraction for Real-Time Reverse Transcription-PCR (rRT-PCR) of SARS-CoV-2: Importance of Internal Control Monitoring.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）实时逆转录聚合酶链反应（rRT-PCR）核糖核酸提取质量：内部控制监测的重要性
Ann Lab Med. 2020 Nov;40(6):490-492. doi: 10.3343/alm.2020.40.6.490. Epub 2020 Jun 17.
9
Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR.7名出院患者经定量逆转录聚合酶链反应检测，新型冠状病毒再次呈阳性。
Am J Infect Control. 2020 Jun;48(6):725-726. doi: 10.1016/j.ajic.2020.03.017. Epub 2020 Apr 10.
10
A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19.一位有 2 型糖尿病病史的患者曾因严重 COVID-19 而康复，现呈现 SARS-CoV-2 RNA 复阳病例。
Diabetes Res Clin Pract. 2020 Aug;166:108300. doi: 10.1016/j.diabres.2020.108300. Epub 2020 Jul 12.
引用本文的文献
1
Risk of SARS-CoV-2 Reinfections Among Healthcare Workers of Four Large University Hospitals in Northern Italy: Results of an Online Survey Within the ORCHESTRA Project.意大利北部四家大型大学医院医护人员中再次感染新冠病毒的风险：ORCHESTRA项目中的一项在线调查结果
Vaccines (Basel). 2025 Jul 31;13(8):815. doi: 10.3390/vaccines13080815.
2
A radiomics based approach using adrenal gland and periadrenal fat CT images to allocate COVID-19 health care resources fairly.一种基于放射组学的方法，利用肾上腺和肾上腺周围脂肪的 CT 图像，公平分配 COVID-19 医疗资源。
BMC Med Imaging. 2023 Nov 10;23(1):181. doi: 10.1186/s12880-023-01145-9.
3
Global prevalence of coronavirus disease 2019 reinfection: a systematic review and meta-analysis.全球 2019 冠状病毒病再感染的流行率：系统评价和荟萃分析。
BMC Public Health. 2023 Apr 28;23(1):778. doi: 10.1186/s12889-023-15626-7.
4
Who Is at Higher Risk of SARS-CoV-2 Reinfection? Results from a Northern Region of Italy.谁感染新冠病毒后再次感染的风险更高？来自意大利北部地区的结果。
Vaccines (Basel). 2022 Nov 8;10(11):1885. doi: 10.3390/vaccines10111885.
5
Does Recovered COVID-19 Patients Have Protective Reactions in Subsequent Reexposures to the Virus?新冠康复患者在后续再次接触病毒时会有保护性反应吗？
Int J Prev Med. 2022 Sep 20;13:114. doi: 10.4103/ijpvm.IJPVM_520_20. eCollection 2022.
6
Patterns of RT-PCR Test Conversion and Implications on Time of Discharge in a District Hospital and a COVID-19 Care Centre in Pali, Rajasthan, India.印度拉贾斯坦邦帕利地区一家区级医院和一家新冠护理中心的逆转录聚合酶链反应（RT-PCR）检测结果转换模式及其对出院时间的影响
Cureus. 2022 Jul 27;14(7):e27325. doi: 10.7759/cureus.27325. eCollection 2022 Jul.
7
Clinical and epidemiological investigation of a child with asymptomatic COVID-19 infection following reoccurrence.一名新冠病毒病无症状感染者复发后的临床及流行病学调查
Health Inf Sci Syst. 2022 Aug 24;10(1):18. doi: 10.1007/s13755-022-00188-6. eCollection 2022 Dec.
8
Prevalence and risk factors associated with repeat positive SARS-CoV-2 nucleic acid test results among discharged COVID-19 patients: A protocol for systematic review and meta-analysis.新冠肺炎出院患者中重复 SARS-CoV-2 核酸检测结果阳性的流行率及其相关因素：系统评价和荟萃分析方案。
Medicine (Baltimore). 2021 Dec 3;100(48):e27933. doi: 10.1097/MD.0000000000027933.
9
The mystery of COVID-19 reinfections: A global systematic review and meta-analysis.新冠病毒再次感染之谜：一项全球系统评价与荟萃分析
Ann Med Surg (Lond). 2021 Dec;72:103130. doi: 10.1016/j.amsu.2021.103130. Epub 2021 Dec 4.
10
Recurrent SARS-CoV-2 infections and their potential risk to public health - a systematic review.反复感染 SARS-CoV-2 及其对公共健康的潜在风险——系统综述。
PLoS One. 2021 Dec 9;16(12):e0261221. doi: 10.1371/journal.pone.0261221. eCollection 2021.
本文引用的文献
1
Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR.7名出院患者经定量逆转录聚合酶链反应检测，新型冠状病毒再次呈阳性。
Am J Infect Control. 2020 Jun;48(6):725-726. doi: 10.1016/j.ajic.2020.03.017. Epub 2020 Apr 10.
2
A case of a readmitted patient who recovered from COVID-19 in Chengdu, China.一名在中国成都从新冠病毒肺炎康复后再次入院的患者病例。
Crit Care. 2020 Apr 16;24(1):152. doi: 10.1186/s13054-020-02877-8.
3
Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者出院后PCR检测反复呈阳性。
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.024. Epub 2020 Apr 11.
4
Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.2020 年 1 月至 2 月，中国两例新冠肺炎（COVID-19）治愈医务人员出院后随访和病毒阳性检出情况。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000191.
5
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.严重急性呼吸综合征冠状病毒 2 再激活的临床特征。
J Infect. 2020 May;80(5):e14-e17. doi: 10.1016/j.jinf.2020.03.001. Epub 2020 Mar 20.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.COVID-19 中 SARS-CoV-2 RNA 复阳：一例报告。
Int J Infect Dis. 2020 Apr;93:297-299. doi: 10.1016/j.ijid.2020.03.003. Epub 2020 Mar 5.
8
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.致命的冠状病毒：2003 年 SARS 大流行和 2020 年中国新型冠状病毒疫情。
J Autoimmun. 2020 May;109:102434. doi: 10.1016/j.jaut.2020.102434. Epub 2020 Mar 3.
9
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
10
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.新冠康复患者体内病毒 RNA 的持续存在与清除。
Chin Med J (Engl). 2020 May 5;133(9):1039-1043. doi: 10.1097/CM9.0000000000000774.
Zotero 插件